Читать книгу Blood and Marrow Transplantation Long Term Management - Группа авторов - Страница 98

This late effect usually develops within a few years of allogeneic‐HCT, but it may occur after 5 years of HCT. Donor‐derived leukemia is a well‐recognized entity [68, 69] along with post‐transplant lymphoproliferative disease [70, 71]. An aggressive diagnostic approach is mandated when leukemia or posttransplant lymphoproliferative disease is suspected late in allogeneic‐HCTs.